Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Space station changes command, setting stage for Crew 11 departure - 2Spots To Go Birdwatching All over the Planet
- 3The Solution to Individual budget: Dominating Cash The board
- 4New ‘Cloud-9’ object could reveal the secrets of dark matter
- 5The most effective method to Pick the Ideal Shrewd Bed for Your Special Rest Needs
- Palestinian leader Abbas says elections only after Gaza war ends
- Figure out how to Perceive Warnings while Looking for an Auto Collision Lawyer
- Starfront Observatories: A haven for distant stargazers
- Your big brain makes you human – count your neurons when you count your blessings
- Tatiana Schlossberg, JFK's granddaughter, dies at 35 after terminal cancer diagnosis
- When darkness shines: How dark stars could illuminate the early universe
- Most loved Well known Accessory Styles For 2024
- Flu season is ramping up, and some experts are "pretty worried"
- Von der Leyen: Paris meeting sends signal of unity for Ukraine
